Apha stock canada globe and mail

You're looking for information on Aphria Inc. (APHQF) stock in Canada, specifically from The Globe and Mail. Here's what I found:

Company Overview: Aphria Inc. is a Canadian cannabis company that cultivates, processes, and distributes medical and recreational cannabis products. The company was founded in 2014 and is headquartered in Leamington, Ontario.

Stock Information: As of March 2023, Aphria Inc.'s stock is listed on the Toronto Stock Exchange (TSX) under the ticker symbol APHA. The company's stock price has been volatile in recent years, influenced by various factors such as changes in the cannabis industry, regulatory developments, and market sentiment.

Recent News and Developments: Here are some recent news articles from The Globe and Mail that may be of interest:

  1. "Aphria's stock surges after company reports narrower-than-expected loss" (February 2023)
  2. "Aphria's cannabis sales decline in latest quarter, but company sees signs of improvement" (November 2022)
  3. "Aphria's stock falls after company reports wider-than-expected loss" (August 2022)
  4. "Aphria to acquire SweetWater Brewing Company in $300-million deal" (June 2022)

Analyst Coverage: Several Canadian banks and investment firms provide analyst coverage for Aphria Inc. Here are some recent analyst ratings and price targets from The Globe and Mail:

  1. TD Securities: "Buy" rating with a price target of $4.50 CAD
  2. CIBC World Markets: "Neutral" rating with a price target of $3.50 CAD
  3. Scotiabank: "Sector Perform" rating with a price target of $3.25 CAD

Please note that analyst ratings and price targets are subject to change and may not reflect the company's current financial situation or future prospects.

Investor Resources: For more information on Aphria Inc. and its stock, you can visit the company's website or consult with a financial advisor. Additionally, you can access Aphria's investor relations page on The Globe and Mail's website, which provides access to news releases, financial statements, and other investor materials.